All Episodes

CGRP in migraine: current therapeutics, future implications and potential off-target effects

Alemtuzumab's impact on functional and structural integrity of the visual system in MS

Guidelines for the management of functional speech and communication disorders

The impact of traumatic brain injury on neurocognitive outcomes in children

Cerebral Microbleeds: from depiction to interpretation

Motor functional neurological disease, a decade of progress

COVID - 19 Vaccination and risk of large vessel arterial stroke

Drug repurposing for progressive multiple sclerosis

Isaacs syndrome the crossroads of Neurology, Psychiatry and Immunology

Apathy, cerebral small vessel disease and future dementia risk

Performance validity tests - Their role in neuropsychology assessments

Parkinson's disease: etiopathogenesis and treatment

Outcome measurement in functional neurological disorder a systematic review and recommendations

Clinical profiles of patients with dementia and chronic traumatic encephalopathy

Visual hallucinations in neurological and ophthalmological disease

Primary Lateral Sclerosis: new consensus criteria

Neurology in the time of COVID - 19

Lithium: a slow burner

Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia

Multifocal motor neuropathy: controversies and priorities

Multiple Systems Atrophy: the nature of the beast revisited

Employment and MS - a patient's perspective

Approaches to Chemotherapy induced peripheral neurotoxicity

Neural circuitry of anxiety

Dementia after traumatic brain injury

Mindfullness in multiple sclerosis

CIDP an update

Movement disorders and seizures

The role of functional neuroimaging in functional neurological disorders

Emotional processing in functional neurological disorder (FND)

Can cocoa help with fatigue in MS

Neurorehabilitation in chronic stroke

The real patient value

Oral immunotherapies in MS a comparison of efficacy.

Medical conferences - what do we get out of them?

Therapeutic trial design in frontotemporal dementias

Do genes affect age of onset in ALS?

The lifetime risk of common neurological disorders in the elderly population

PMA and PLS: are they really restricted phenotypes?

Statins and the risk of recurrent intracerebral haemorrhage (ICH) – what does the evidence say?

Functional impairment and improvement

Can computational models help us understand complex movement disorders?

Idiopathic intracranial hypertension: guidelines for diagnosis and management

Nusinersen for SMA

Expanding clinical spectrums in both Kennedy's disease and poststroke syndromes

The use of cannabis in epilepsy, and surgery for tremor

Epilepsy an evidence update

The Use of Frankincense Extract In MS

A new questionnaire to measure quality of life in inflammatory neuropathies

Marriage and a reduced risk of dementia

Anti-inflammatory approaches to stroke prevention; monitoring disease progression in ALS

Nodes and paranodes; alternative treatments in MS

Pathophysiology of functional neurological disorder

Is methamphetamine use linked to stroke in young adults?

Cerebral Amyloid Angiopathy: New Insights For Clinical Practice

Cortical Influences in ALS

Intravenous immunoglobulin in CIDP

Complex inherited neuropathies: a new approach to diagnosis?

Cerebellum and neurodegeneration; autoantibodies and psychological development in children

Time Matters - part 2: how the real costs of multiple sclerosis are being concealed

Survival and cause of death in Multiple Sclerosis

Time Matters - part 1: delay is “expensive” in all aspects of multiple sclerosis

Seven tesla MRI In Neurodegenerative Dementias

Conversational Laughter In Dementia

Narrative and Neurology: The Andrew Lees Experiment

April 2017: deconstructing dilemmas in Amyotrophic Lateral Sclerosis and Guillain-Barré Syndrome

Zika virus and Guillain-Barré Syndrome: what do we know?

Immunomodulatory therapy in advanced multiple sclerosis

A clinical tool for predicting survival in motor neurone disease

The relationship between orthostatic hypotension and cognitive impairment in α-synucleinopathies

Latitude and disease severity in Multiple Sclerosis

Do your kids play rugby? Risks for rugby union players from repeated concussions

Genetics and the clinical course of multiple sclerosis

Is it time to focus on the common pathways linking neurodegenerative diseases?

October 2016 Edition: long-term outcomes after stroke; hereditary and inflammatory neuropathies

Smoking: a negative prognostic for survival in motor neurone disease patients

Selective vulnerability in clinical variants of Alzheimer's Disease

Review: Amyotrophic Lateral Sclerosis and Motor Neuron Syndromes in Asia

Automated brain volumetrics in multiple sclerosis, plus migraine and psychiatric co-morbidities

Coffee consumption and multiple sclerosis

June Edition: Parkinson’s disease and the rate of ALS progression

Sudden Unexpected Death in Epilepsy: basic mechanisms and implications for prevention

Re-evaluating the treatment of acute optic neuritis

BNPA 2015: Spatial Neglect

BNPA 2015: New theories of memory systems and networks

BNPA 2015: Phantom phenomena

Clinical neurology: why this still matters in the 21st century

Imaging outcomes for trials of remyelination in multiple sclerosis

BNPA 2014: Oxytocin and social cognition

BNPA 2014: Schizophrenia and cognition

Advances in epilepsy surgery

Brain atrophy and disability progression in multiple sclerosis patients

BNPA 2014: Joint hypermobilty and autonomic hyperactivity

BNPA 2014: Post-Ictal psychosis

BNPA 2014: TREM2 variants and risk of dementia

Neurosurgical procedures for psychiatric illness

Can stress trigger Parkinson's? And new criteria for frontotemporal dementia syndromes.

HIV and multiple sclerosis: beginning to unravel a mystery

BNPA 2014: Neuropsychiatry of social knowledge and moral motivation

DBS in essential tremor, and genetic counselling for ALS